niclosamide has been researched along with Koch's Disease in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Le, NH | 1 |
Constant, P | 1 |
Tranier, S | 1 |
Nahoum, V | 1 |
Guillet, V | 1 |
Maveyraud, L | 1 |
Daffé, M | 1 |
Mourey, L | 1 |
Verhaeghe, P | 1 |
Marrakchi, H | 1 |
Fan, X | 1 |
Xu, J | 1 |
Files, M | 1 |
Cirillo, JD | 1 |
Endsley, JJ | 1 |
Zhou, J | 1 |
Endsley, MA | 1 |
2 other studies available for niclosamide and Koch's Disease
Article | Year |
---|---|
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium | 2022 |
Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
Topics: Anti-HIV Agents; Antitubercular Agents; Coinfection; HIV-1; Humans; Jurkat Cells; Macrophages; Mycob | 2019 |